NXE shorts nearly double in a month as earnings loom

NXE heads into its November 4 results with short sellers the most aggressive they have been all year, even as the borrow market remains far from stressed.

The short interest story is the standout on NexGen Energy this week. Positions have nearly doubled over the past month, rising 84% to 4.3% of the free float, with a further 9% added in each of the last day and week alone. The daily estimate now shows roughly 28.4 million shares short, up from around 15.5 million at mid-September. That is a rapid build for a stock in the pre-revenue development stage, and it coincides with NXE falling 10% over the past month to CAD 11.66, a 2.3% bounce on Monday notwithstanding. The ORTEX short score has ticked up to 54.8, with readings generally in the 52 to 57 range across the past two weeks, suggesting the signal has turned moderately negative but not yet into extreme territory.

Despite the speed of the short build, the borrow market is not flashing stress. Availability remains generous at around 147%, meaning roughly 1.5 shares are still available to borrow for every share already out on loan. That compares to a 52-week low availability of 86% and a peak utilization rate of 55%, so the lending pool has tightened since September but is nowhere near capacity. Cost to borrow is running below 0.8%, categorised as low, and has been range-bound between 0.6% and 1.2% for the past six weeks. Shorts face no meaningful squeeze pressure from the mechanics of the borrow market, which makes the position build look conviction-driven rather than technically trapped.

On the Street, analyst data for NXE is stale and should not be leaned on: the most recent consensus information is more than five years old and carries a mean target well below the current price. What the factor scores do indicate is that earnings momentum is weak, with the 30-day and 90-day EPS momentum readings ranking in the 7th and 5th percentile respectively, and EPS surprise in the 2nd percentile. Forward EPS growth expectations remain elevated (80th percentile), anchored to the long-run nuclear demand thesis rather than near-term cash generation. The price-to-book multiple has drifted down about 0.46 points over the past 30 days to 3.7x, reflecting the share price decline. NXE is pre-revenue and loss-making, so most income multiples are negative and not directly comparable to producing peers.

The uranium peer group has also struggled this week. CCO fell 2.6%, DML dropped 3.7%, and UEC shed 5.7%. EFR was the worst of the group, down more than 8%. NXE's own 2.8% weekly decline puts it roughly in the middle of the pack. The sector-wide softness suggests the short build on NXE is not purely a stock-specific view: broader uranium sentiment has cooled heading into the autumn, and the correlation between NXE and its closest peers is running above 80%.

Institutional holders are concentrated in funds with explicit uranium or resources mandates. Van Eck added 8.5 million shares through to September 30, bringing its position to roughly 5.9% of shares. ALPS Advisors added another 3.1 million shares over the same period. On the 13D/G register, no activist holder is present, and Barclays trimmed below the 5% reporting threshold as of February; per the disclosure caveat, that stake may have changed further without a subsequent filing.

The November 4 print is therefore less about a revenue surprise, NexGen has none, and more about project construction timelines, permitting status at Rook I, and any financing or offtake updates that could shift the thesis on first production timing.